Intrinsic Value

Fate Therapeutics, Inc. (FATE)

$7.34

+0.01 (+0.00%)

Enterprise Value -42,924.85
Net Debt 61.67
Equity Value -42,986.52
Shares Outstanding 98.41
Equity Value Per Share -436.81



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt